title: Assessment of children with the overt aggression scale.
abstract: Aggressive behavior is difficult to capture with most available rating instruments because it occurs with low frequency. The Overt Aggression Scale (OAS) was designed to capture all incidents on a 24-hour basis. To assess its usefulness, the OAS was piloted on 16 hospitalized, severely aggressive children with conduct disorder. OAS ratings capture episodes of aggressive behavior, measure trends in aggressive behavior over time, and appear to reflect change associated with pharmacotherapy in hospitalized children. This study suggests that the use of the OAS on a children's psychiatric inpatient unit is appropriate and feasible for clinical as well as research purposes.
authors.affiliation: Department of Psychiatry, New York University Medical Center, New York, New York, USA.
authors.forename: V
authors.initials: V
authors.lastname: Kafantaris
authors.forename: D O
authors.initials: DO
authors.lastname: Lee
authors.forename: H
authors.initials: H
authors.lastname: Magee
authors.forename: G
authors.initials: G
authors.lastname: Winny
authors.forename: R
authors.initials: R
authors.lastname: Samuel
authors.forename: S
authors.initials: S
authors.lastname: Pollack
authors.forename: M
authors.initials: M
authors.lastname: Campbell
mesh_terms: D000374:Aggression; D002220:Carbamazepine / Q000627:therapeutic use; D002648:Child; D002653:Child Behavior Disorders / Q000175:diagnosis* / Q000188:drug therapy; D002675:Child, Preschool; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D008297:Male; D010919:Placebos / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000627:therapeutic use; D012720:Severity of Illness Index
chemical_list: D010919:Placebos; D011619:Psychotropic Drugs; D002220:Carbamazepine; D008094:Lithium; D006220:Haloperidol